Read more
12:56 PM · 1 July 2022

Micron Technology tumbles in pre-market on gloomy financial outlook

-
-
Open account Download free app

Micron Technology (MU.US) stock fell more than 4% before the opening bell, as weak revenue guidance overshadowed better than expected earnings figures.

  • Company earned an adjusted $2.59 a share on sales of $8.64 billion. Wall Street expected earnings of $2.43 a share on sales of $8.64 billion. Micron earnings jumped 38% YoY while sales rose 16% YoY.
  • Company forecasts smartphone sales to be meaningfully lower than previously expected for the rest of 2022, citing a reduction in consumer demand as rising inflation and recession squeeze consumers and corporate spending.
  • “The industry demand environment has weakened,” CEO Sanjay Mehrotra said.  This was confirmed by yesterday's U.S. personal spending data, which showed decreasing demand of durable goods, from autos to electronics.
  • Micron forecasts that PC sales will fall nearly 10% this year, while smartphone shipments could plunge 6%, therefore the company plans to “moderate” its output growth accordingly.
  • For the Q4 Micron forecasts diluted earnings per share in the region between $1.43 and $1.83 on revenue of $6.8B and $7.6B. Analyst forecasts had seen EPS at $2.69, with sales of $9.31B.
  • Micron’s warning indicates that the chipmaker market is starting to show weakness after two years where the pandemic boosted sales as many companies and schools moved to work from home models.

Micron Technology (MU.US) stock fell sharply in premarket and if current sentiment prevails downward move may accelerate towards support zone around $46.00, which is marked with lower limit of the 1:1 structure and 78.6% Fibonacci retracement of the bullish wave started in March 2020. Source: xStation5

10 March 2026, 1:01 PM

Nvidia expands into software AI sector? Wired reports on NemoClaw

10 March 2026, 12:59 PM

Market Wrap: Energy Stocks Retreat as Hopes for End to Iran War Grow 🌍 (10.03.2026)

9 March 2026, 5:40 PM

Live Nation climbs on antitrust deal

9 March 2026, 4:30 PM

Is the FDA sabotaging medical companies? UniQure’s valuation rollercoaster

Join over 2 000 000 XTB Group Clients from around the world
The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits